ChemPartner PharmaTech Co Ltd
Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services. The company provides comprehe… Read more
ChemPartner PharmaTech Co Ltd (300149) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: 0.012x
Based on the latest financial reports, ChemPartner PharmaTech Co Ltd (300149) has a cash flow conversion efficiency ratio of 0.012x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥28.21 Million) by net assets (CN¥2.37 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ChemPartner PharmaTech Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how ChemPartner PharmaTech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ChemPartner PharmaTech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ChemPartner PharmaTech Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
WAORF
PINK:WAORF
|
N/A |
|
SFA Semicon Co. Ltd
KQ:036540
|
-0.016x |
|
Petrovietnam Gas JSC
VN:GAS
|
0.012x |
|
AngioDynamics Inc
NASDAQ:ANGO
|
0.026x |
|
Lanzhou Greatwall Electrical Co Ltd
SHG:600192
|
-0.019x |
|
CHORUS AVIAT.(VOT.+VAR.)
F:1H0
|
N/A |
|
Rusta AB (publ)
ST:RUSTA
|
0.081x |
|
Better Collective A/S
PINK:BTRCF
|
0.036x |
Annual Cash Flow Conversion Efficiency for ChemPartner PharmaTech Co Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of ChemPartner PharmaTech Co Ltd from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.24 Billion | CN¥168.21 Million | 0.136x | +31.45% |
| 2023-12-31 | CN¥1.46 Billion | CN¥150.99 Million | 0.103x | -6.04% |
| 2022-12-31 | CN¥2.39 Billion | CN¥262.46 Million | 0.110x | -42.15% |
| 2021-12-31 | CN¥1.99 Billion | CN¥378.22 Million | 0.190x | +35.89% |
| 2020-12-31 | CN¥2.45 Billion | CN¥343.16 Million | 0.140x | +49.86% |
| 2019-12-31 | CN¥2.30 Billion | CN¥215.07 Million | 0.093x | -15.36% |
| 2018-12-31 | CN¥2.20 Billion | CN¥243.19 Million | 0.110x | +45.29% |
| 2017-12-31 | CN¥835.45 Million | CN¥63.43 Million | 0.076x | -17.96% |
| 2016-12-31 | CN¥769.93 Million | CN¥71.26 Million | 0.093x | -33.47% |
| 2015-12-31 | CN¥723.81 Million | CN¥100.69 Million | 0.139x | +62.47% |
| 2014-12-31 | CN¥696.53 Million | CN¥59.63 Million | 0.086x | +23.89% |
| 2013-12-31 | CN¥670.29 Million | CN¥46.32 Million | 0.069x | -19.60% |
| 2012-12-31 | CN¥640.90 Million | CN¥55.09 Million | 0.086x | +350.62% |
| 2011-12-31 | CN¥611.46 Million | CN¥11.66 Million | 0.019x | -47.63% |
| 2010-12-31 | CN¥571.30 Million | CN¥20.81 Million | 0.036x | -72.23% |
| 2009-12-31 | CN¥101.26 Million | CN¥13.28 Million | 0.131x | -64.72% |
| 2008-12-31 | CN¥58.36 Million | CN¥21.70 Million | 0.372x | -59.35% |
| 2007-12-31 | CN¥24.25 Million | CN¥22.19 Million | 0.915x | -- |